Press "Enter" to skip to content

New patent expiration for Acorda drug INBRIJA

3
Copyright © DrugPatentWatch. Originally published at New patent expiration for Acorda drug INBRIJA

Annual Drug Patent Expirations for INBRIJA
Annual Drug Patent Expirations for INBRIJA

Inbrija is a drug marketed by Acorda and is included in one NDA. It is available from one supplier. There are eighteen patents protecting this drug.

This drug has one hundred and thirty-three patent family members in twenty-six countries.

The generic ingredient in INBRIJA is levodopa. One supplier is listed for this compound. Additional details are available on the levodopa profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent expiration for Acorda drug INBRIJA

Comments are closed.

Get the DrugPatentWatch Daily Briefing

✓ Patent Expirations and Generic Entry

✓ Insightful Articles & Case Studies

✓ Patent Litigation & Challenges

✓ 505(b)(2) & Biosimilars

✓ Industry Trends

Do NOT follow this link or you will be banned from the site!